
### [MONDO:0020040](http://purl.obolibrary.org/obo/MONDO_0020040)
**Label:** 46,XY disorder of sex development

**Subclasses:** [MONDO:0009384](http://purl.obolibrary.org/obo/MONDO_0009384) (leydig cell hypoplasia, type 1), [MONDO:0008681](http://purl.obolibrary.org/obo/MONDO_0008681) (WAGR syndrome), [MONDO:0017971](http://purl.obolibrary.org/obo/MONDO_0017971) (46,XY disorder of sex development due to a cholesterol synthesis defect), [MONDO:0016674](http://purl.obolibrary.org/obo/MONDO_0016674) (46,XY partial gonadal dysgenesis), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0017970](http://purl.obolibrary.org/obo/MONDO_0017970) (46,XY disorder of sex development due to impaired androgen production), [MONDO:0019155](http://purl.obolibrary.org/obo/MONDO_0019155) (leydig cell hypoplasia), [MONDO:0019595](http://purl.obolibrary.org/obo/MONDO_0019595) (46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0019596](http://purl.obolibrary.org/obo/MONDO_0019596) (46,XY disorder of sex development due to testicular steroidogenesis defect), [MONDO:0019154](http://purl.obolibrary.org/obo/MONDO_0019154) (androgen insensitivity syndrome), [MONDO:0019594](http://purl.obolibrary.org/obo/MONDO_0019594) (46,XY disorder of sex development due to a testosterone synthesis defect), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0020041](http://purl.obolibrary.org/obo/MONDO_0020041) (46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue), [MONDO:0020042](http://purl.obolibrary.org/obo/MONDO_0020042) (syndrome with 46,XY disorder of sex development), [MONDO:0007251](http://purl.obolibrary.org/obo/MONDO_0007251) (campomelic dysplasia), [MONDO:0018618](http://purl.obolibrary.org/obo/MONDO_0018618) (46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect), [MONDO:0017969](http://purl.obolibrary.org/obo/MONDO_0017969) (46,XY disorder of sex development of endocrine origin), [MONDO:0010765](http://purl.obolibrary.org/obo/MONDO_0010765) (46,XY complete gonadal dysgenesis), [MONDO:0017966](http://purl.obolibrary.org/obo/MONDO_0017966) (46,XY disorder of gonadal development), 

**Corr. equiv. classes:** [Orphanet:98087](http://www.orpha.net/ORDO/Orphanet_98087), [Orphanet:242](http://www.orpha.net/ORDO/Orphanet_242), [OMIM:300068](http://purl.obolibrary.org/obo/OMIM_300068), [Orphanet:140](http://www.orpha.net/ORDO/Orphanet_140), [Orphanet:98086](http://www.orpha.net/ORDO/Orphanet_98086), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [Orphanet:251510](http://www.orpha.net/ORDO/Orphanet_251510), [OMIM:114290](http://purl.obolibrary.org/obo/OMIM_114290), [Orphanet:90790](http://www.orpha.net/ORDO/Orphanet_90790), [OMIM:194072](http://purl.obolibrary.org/obo/OMIM_194072), [Orphanet:90793](http://www.orpha.net/ORDO/Orphanet_90793), [Orphanet:755](http://www.orpha.net/ORDO/Orphanet_755), [Orphanet:754](http://www.orpha.net/ORDO/Orphanet_754), [Orphanet:893](http://www.orpha.net/ORDO/Orphanet_893), [OMIM:201710](http://purl.obolibrary.org/obo/OMIM_201710), [Orphanet:443090](http://www.orpha.net/ORDO/Orphanet_443090), [Orphanet:325118](http://www.orpha.net/ORDO/Orphanet_325118), [Orphanet:325357](http://www.orpha.net/ORDO/Orphanet_325357), [Orphanet:325511](http://www.orpha.net/ORDO/Orphanet_325511), [Orphanet:325351](http://www.orpha.net/ORDO/Orphanet_325351), [Orphanet:90786](http://www.orpha.net/ORDO/Orphanet_90786), [Orphanet:90787](http://www.orpha.net/ORDO/Orphanet_90787), [OMIM:400044](http://purl.obolibrary.org/obo/OMIM_400044), [OMIM:238320](http://purl.obolibrary.org/obo/OMIM_238320), [Orphanet:90783](http://www.orpha.net/ORDO/Orphanet_90783), 

**Class expressions from DL-Learner:**

- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 51.65%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0000598](http://purl.obolibrary.org/obo/HP_0000598) (Abnormality of the ear))) 51.65%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0008209](http://purl.obolibrary.org/obo/HP_0008209) (Premature ovarian insufficiency))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0000496](http://purl.obolibrary.org/obo/HP_0000496) (Abnormality of eye movement))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck))) 50.15%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 48.82%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology))) 48.82%
- [HP:0000837](http://purl.obolibrary.org/obo/HP_0000837) (Increased circulating gonadotropin level) and (not ([HP:0100000](http://purl.obolibrary.org/obo/HP_0100000) (Early onset of sexual maturation))) 48.82%


